浩宇生醫股份有限公司
浩宇生醫股份有限公司為醫療器材公司，在台灣研發並銷售聚焦超音波 (FUS) 解決方案，以滿足神經醫學之需求。公司研發 NaviFUS 導航引導經顱聚焦超音波系統，用於腦部精準遞送藥物、神經調控及免疫刺激等臨床應用。亦研發 NAVIRFA 導航系統，利用光學 3D 手術追蹤技術監控針尖位置。公司成立於 2015 年，總部位於台灣台北市。
今日下跌 3.66%，股價跌破短期均線。該股 RSI(6) 為 51.0，處於中性區間，短線無明顯超買超賣訊號。股價站上20日、60日、120日均線，跌破5日均線。短中期均線呈多頭排列，趨勢偏多。KD 指標中性（K=36.8）；MACD 柱狀體為正值，維持多方動能。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 09-24 | +2 | 0 | 0 | +2 |
| 09-23 | -29 | 0 | 0 | -29 |
| 09-22 | -114 | 0 | +2 | -118 |
| 09-21 | +179 | 0 | +9 | +183 |
| 09-18 | -5 | 0 | 0 | -5 |
| 09-17 | -6 | 0 | +4 | -6 |
| 09-15 | +3 | 0 | 0 | +3 |
| 09-11 | +1 | 0 | 0 | +1 |
| 09-10 | -32 | 0 | 0 | -32 |
| 09-09 | 0 | 0 | 0 | -3 |
| 09-08 | 0 | 0 | +5 | +2 |
| 09-07 | 0 | 0 | 0 | -1 |
| 09-04 | +10 | 0 | +2 | +10 |
| 09-03 | +30 | 0 | +2 | +31 |
| 09-02 | -6 | 0 | +2 | -6 |
| 09-01 | 0 | 0 | 0 | 0 |
| 08-31 | -1 | 0 | 0 | -1 |
| 08-28 | -6 | 0 | +3 | -5 |
| 08-27 | -2 | 0 | 0 | -2 |
| 08-25 | -5 | 0 | 0 | -5 |
| 08-24 | -2 | 0 | 0 | -2 |
| 08-20 | +2 | 0 | 0 | +2 |
| 08-19 | -2 | 0 | 0 | -2 |
| 08-18 | +2 | 0 | +2 | +2 |
| 08-17 | -3 | 0 | 0 | -3 |
| 08-13 | 0 | 0 | 0 | 0 |
| 08-12 | +2 | 0 | 0 | +2 |
| 08-07 | -2 | 0 | +1 | -3 |
| 08-06 | -2 | 0 | 0 | -2 |
| 08-05 | 0 | 0 | +1 | +1 |
| 08-03 | +4 | 0 | 0 | +4 |
| 07-31 | +11 | 0 | 0 | +11 |
| 07-30 | -7 | 0 | 0 | -7 |
| 07-29 | -10 | 0 | 0 | -10 |
| 07-28 | -1 | 0 | 0 | -1 |
| 07-27 | -2 | 0 | 0 | -2 |
| 07-24 | 0 | 0 | 0 | 0 |
| 07-23 | +2 | 0 | 0 | +2 |
| 07-22 | 0 | 0 | +2 | +1 |
| 07-21 | +1 | 0 | 0 | +1 |
| 07-17 | -1 | 0 | 0 | -1 |
| 07-16 | 0 | 0 | +2 | +1 |
| 07-15 | +5 | 0 | 0 | +5 |
| 07-14 | -3 | 0 | 0 | -3 |
| 07-13 | +2 | 0 | 0 | +2 |
| 07-08 | 0 | 0 | 0 | -4 |
| 07-07 | +3 | 0 | 0 | +3 |
| 07-06 | +4 | 0 | 0 | +4 |
| 07-03 | +4 | 0 | 0 | +4 |
| 07-02 | -4 | 0 | +2 | -3 |
| 07-01 | +4 | 0 | 0 | +4 |
| 06-30 | +1 | 0 | 0 | +1 |
| 06-26 | -11 | 0 | 0 | -11 |
| 06-22 | -1 | 0 | 0 | -1 |
| 06-18 | +1 | 0 | 0 | +1 |
| 06-17 | -1 | 0 | 0 | -1 |
| 06-15 | -1 | 0 | 0 | -1 |
| 06-12 | -2 | 0 | 0 | -2 |
| 06-08 | +5 | 0 | 0 | +5 |
| 06-05 | -1 | 0 | 0 | -1 |
| 06-01 | +1 | 0 | 0 | +1 |
| 05-29 | +2 | 0 | 0 | +2 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/04 | 130 萬 | -92.3% | +226.3% |
| 2026/03 | 1692 萬 | +2443.9% | +4172.0% |
| 2026/02 | 66 萬 | +1.1% | +80.7% |
| 2026/01 | 66 萬 | -3.7% | +88.0% |
| 2025/12 | 68 萬 | +6.2% | -44.3% |
| 2025/11 | 64 萬 | -7.6% | - |
| 2025/10 | 70 萬 | +4.7% | - |
| 2025/09 | 66 萬 | -73.0% | - |
| 2025/08 | 246 萬 | +308.3% | - |
| 2025/07 | 60 萬 | -60.4% | - |
| 2025/06 | 152 萬 | -10.6% | - |
| 2025/05 | 170 萬 | - | - |